Back to Resource Center

In vitro exposure to PC-1005 and cervicovaginal lavages from women vaginally administered PC-1005 inhibit HIV-1 and HSV-2 infection in human cervical mucosa

July 2016

Click to view Journal Article

Click for full info +

In vitro exposure to PC-1005 and cervicovaginal lavages from women vaginally administered PC-1005 inhibit HIV-1 and HSV-2 infection in human cervical mucosa

In vitro exposure to PC-1005 and cervicovaginal lavages from women vaginally administered PC-1005 inhibit HIV-1 and HSV-2 infection in human cervical mucosa
05 July 2016
In this Journal Article:
Health Risk(s):

  • HIV
  • HSV
  • Product Type(s):

  • Microbicides
  • Topic(s):

  • Reproductive Health

  • Full Info:


    Resource Type:

    Journal Article

    Citation:

    Villegas, G., Calenda, G., Zhang, S., Mizenina, O., Kleinbeck, K., Cooney, M.L., … Teleshova, N. (2016, July 5). Antimicrobial Agents and Chemotherapy. 

    Authors:

    Villegas, G., Calenda, G., Zhang, S., Mizenina, O., Kleinbeck, K., Cooney, M.L., … Teleshova, N. 

    Health Risks(s):

    • HIV
    • HSV

    Product type(s):

    • Microbicide

    Topic(s):

    • Reproductive Health

        URL of resource:

        http://aac.asm.org/content/early/2016/06/28/AAC.00392-16.abstract

        Back to Resource Center